RCP is a human breast cancer-promoting gene with Ras-activating function

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Aggressive cancers often have chromosomal alterations, but underlying genetic drivers are unclear.
• Identifying oncogenes is crucial for understanding and treating aggressive breast cancer.
• The 8p11-12 chromosomal region, amplified in breast cancer, harbors potential oncogenes.

Purpose of the Study:

• To identify candidate oncogenes contributing to aggressive breast cancer using microarray informatics.
• To investigate the role of the Rab-coupling protein RCP (RAB11FIP1) in breast cancer development and progression.

Main Methods:

• Microarray informatics to identify candidate oncogenes.
• Overexpression and knockdown studies in human mammary epithelial and breast cancer cell lines.
• In vitro assays for tumorigenic properties (e.g., growth, invasion, migration).
• Mouse xenograft models to assess tumor formation and metastasis.
• Analysis of ERK phosphorylation and Ras activation.

Main Results:

• Rab-coupling protein RCP (RAB11FIP1) was identified as a candidate oncogene at the amplified 8p11-12 locus.
• RCP overexpression induced tumorigenic properties in normal mammary cells.
• RCP knockdown inhibited cancer cell proliferation, invasion, and migration in vitro.
• RCP knockdown reduced tumor growth and metastasis in vivo.
• RCP overexpression enhanced ERK phosphorylation and Ras activation.

Conclusions:

• RCP is a multifunctional oncogene amplified in breast cancer with Ras-activating function.
• RCP plays a significant role in promoting breast cancer aggressiveness, tumor formation, and metastasis.
• RCP represents a potential therapeutic target for aggressive breast cancer.
• These findings highlight the role of Rab proteins and their interactors in carcinogenesis.